学术探索
学术期刊
新闻热点
数据分析
智能评审

To Market, To Market-2006

被引：15
作者：
Hegde, Shridhar [1 ]
Schmidt, Michelle [1 ]
机构：
[1] Pfizer Inc, St Louis, MO 63017 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42032-2
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：505 / 554
页数：50
相关论文
共 136 条
[131]   Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonist [J].
Wu, CD ;
Decker, ER ;
Blok, N ;
Bui, H ;
You, TJ ;
Wang, JM ;
Bourgoyne, AR ;
Knowles, V ;
Berens, KL ;
Holland, GW ;
Brock, TA ;
Dixon, RAF .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) :1969-1986
[132]  
YAMAGUCHI T, 2006, Patent No. 06046499
[133]  
Yuen Man-Fung, 2005, Expert Rev Anti Infect Ther, V3, P489, DOI 10.1586/14787210.3.4.489
[134]   Rotigotine: A novel dopamine agonist for the transdermal treatment of Parkinson's disease [J].
Zareba, G .
DRUGS OF TODAY, 2006, 42 (01) :21-28
[135]   Oral varenicline for smoking cessation [J].
Zierler-Brown, Seena L. ;
Kyle, Jeffrey A. .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) :95-99
[136]  
2006, DRUGS R D, V7, P254
567891011121314